Document Details |
|
Name of Department/Committee : | MHD 12 |
---|---|
Document Number : | MHD 12 ( 23655) |
Document Title [English] : | Plastic Containers for Intravenous Injections |
Document Title [Hindi] : | इंट्रावेनस इंजेक्शन के लिए प्लास्टिक कंटेनर |
Document Type : | New |
Language : | English |
Priority : | 2 |
ICS Code : | 11.040.20 |
Date of Project Approval : | 25-09-2023 |
Standards to be Superseded : |
Classification Details |
|
Group : | Medical and Hospital Equipments |
Sub Group : | Health care facilities |
Sub Sub Group : | Surgical dressings and Disposable products |
Aspects : | Product Specification |
Risk : | Medium |
Certification : | Voluntary Certification |
Short Commom Man's Title : | |
ITCHS Code : | |
Ministry : |
|
Sustainable development Goals : | |
Degree of Equivalence : | Identical under dual numbering |
Identical/Equivalent Standards : | ISO 15747:2018 |
Organization Type: | ISO |
::Cross Referenced Indian Standard:: |
|||
Sl. No. | Is No & Year | IS Title | |
1 | IS 2102 : Part 1: 1993 | General tolerances: Part 1 tolerances for linear and angular dimensions without individual tolerance indications (Third Revision) | |
2 | IS 17894 : 2022 | Geometrical product specifications GPS - Geometrical tolerancing - General geometrical specifications and general size specifications | |
3 | IS/ISO 8536 : Part 4: 2019 | Infusion equipment for medical use Part 4: Infusion sets for single use gravity feed | |
4 | IS 17932 : Part 1: 2023 | Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process | |
5 | IS/ISO 10993 : Part 5: 2009 | Biological evaluation of medical devices Part 5 Tests for in vitro cytotoxicity |
Sl.No. | Synosis Points | |
1 | This document specifies requirements to the safe handling and the physical, chemical and biological testing of plastic containers for parenterals. | |
2 | This document is applicable to plastic containers for parenterals having one or more chambers and having a total nominal capacity in the range of 50 ml to 5 000 ml such as film bags or blow-moulded plastic bottles for direct administration of infusion (injection) solutions. |
Timeline Details |
|||||||
|
|||||||
|
|||||||
|
|||||||
Stages |
|||||
Sl. No. |
Stage | Date of Occurence | Remarks | Circulated to | Files |
1 | Generation of Document Number | 25-09-2023 | ------- | ||
2 | P-Draft Waived | 25-09-2023 | ------- | ||
3 | WC Draft | 25-09-2023 | Duration : 30 Days Submitted for HOD approval |
------- | |
4 | WC Draft | 25-09-2023 | WC approved by HOD |
MHDC MHD 12, | ------- |
5 | WC-Draft | 03-10-2023 | WC-Draft Email Notifications Sent | MHDC, MHD 12, | ------- |
6 | WC-Draft | 03-10-2023 | WC-Draft Email Notifications Sent | MHDC, MHD 12, | ------- |
7 | Skipped to Finalization | 18-04-2024 | Stage-Changed | ------- | |
8 | Finalization | 18-04-2024 | ------ | ------- | |
9 | Final Draft | 18-04-2024 | Submited for HOD approval |
------- | |
10 | Final Draft draft accepted by HOD and sent to Publication | 19-04-2024 | Final Draft approved by HOD | ------- | |
11 | Accepted by Publication | 22-04-2024 | Final Draft accepted by Publication Remarks: Accepted by Publication |
------- |